| abstract |
[PROBLEMS] To treat or prevent one or more conditions selected from type 1 diabetes, type 2 diabetes, impaired glucose tolerance and hyperglycemia using SGLT-2 inhibitors, as well as prevention of metabolic disorders and related conditions. Alternatively, a method of treatment is provided. The present invention relates to the following formula I: wherein R1 represents Cl, methyl or cyano; R2 represents H, methyl, methoxy or hydroxy; and R3 represents ethyl, cyclopropyl, ethynyl. , Ethoxy, (R) -tetrahydrofuran-3-yloxy or (S) -tetrahydrofuran-3-yloxy)) or a prodrug SGLT2 inhibitor It is related with the method characterized by this. [Selection figure] None |